Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia
Karen L. Bride(Cohen Children's Medical Center), David T. Teachey(Children's Hospital of Philadelphia), Mignon L. Loh(Seattle Children's Hospital), Brent L. Wood(University of Southern California), Stephen P. Hunger(Children's Hospital of Philadelphia), Elizabeth A. Raetz(NYU Langone Health), Tina Glisovic‐Aplenc(Children's Hospital of Philadelphia), Yunfeng Dai(University of Florida), Richard Aplenc(Children's Hospital of Philadelphia), David M. Barrett(Children's Hospital of Philadelphia), Shannon L. Maude(Children's Hospital of Philadelphia), Robin Carson(Janssen (United States)), Kimberly P. Dunsmore(University of Virginia), Terzah M. Horton(Unknown), Stuart S. Winter(New Mexico Cancer Center), Tiffaney L. Vincent(Children's Hospital of Philadelphia), Stephan A. Grupp(Children's Hospital of Philadelphia), Tori J. Fuller(Children's Hospital of Philadelphia), William L. Carroll(NYU Langone Health), Michelle L. Hermiston(VinUniversity), Meenakshi Devidas(National Institutes of Health), Soo-Yeon Im(Children's Hospital of Philadelphia)
Cited by 226
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|1.2k